Arranon
Active Ingredient(s): NelarabineFDA Approved: * October 28, 2005
Pharm Company: * SMITHKLINE BEECHAM
Category: Cancer
Nelarabine, sold under the brand names Arranon (US) and Atriance (EU), is a chemotherapy medication used for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). Nelarabine is a prodrug of arabinosylguanine nucleotide triphosphate (araGTP), a type of purine nucleoside analog, which causes inhibition of DNA synthesis and cytotoxicity.[3] Pre-clinical studies suggest that T-cells are particularly sensitive to nelarabine. In Oc... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.